Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems
13th Nov 2006, 19:52 GMT
Bio-Rad Laboratories, Inc. (AMEX: BIO) (AMEX: BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the...
Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems related news:
- Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems — Financial News News from StratCenter.com
- Bio-Rad Laboratories: Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems — Market Wire - Medical and Healthcare
- Ciphergen Completes Sale of Life Science Research Business to Bio-Rad Labs — StratWire - Business of Healthcare NewsFeed
- Bio-Rad Closes Buy of Ciphergen Unit — Financial News News from StratCenter.com
- Ciphergen Completes Sale of Life Science Research Business to Bio-Rad Laboratories — PR Newswire: All Releases
- High performance evaporator is affordable — Laboratory equipment and wares latest news on Laboratorytalk
- CLC bio Expands Product Line with Kapelan's 1D Gel Analysis Software — PressReleaseNetwork.com: News Feed
- Advanced Viral Research Files an Amendment to its Existing IND to Include Topical and Intralesional Therapy — Bio-Technology News from StratCenter.com
- RAD präsentiert SHDSL-Modem der neuen Generation für Ethernet-Access über Kupferleitungen — openPR.de Newsfeed
- Philanthropist rethinks science funding — Business
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL